← Back to results

Posted · PAR-27-072

Bioengineering Research Grants (BRG) (R01 Clinical Trial Optional)

National Institutes of Health  ·  HHS

CFDA Numbers

93.393, 93.394, 93.395, 93.396, 93.399, 93.865, 93.867

Award Ceiling

$500K

Award Floor

Expected Awards

Close Date

Jul 5, 2029

Section I

How to Apply

View on grants_gov ↗

Program Contact

Bioengineering Research Grants, NCI<br/>bioengineeringresearchgrants@mail.nih.gov
bioengineeringresearchgrants@mail.nih.gov

Section II

Eligibility

Refer to Section III. Eligibility Information in the NOFO for additional information on eligibility.Foreign Organizations/International Collaborations:Non-domestic (non-U.S.) Entities (Foreign Organizations) are eligible to apply.Non-domestic (non-U.S.) components of U.S. Organizations are eligible to apply.Foreign components, as defined in the NIH Grants Policy Statement, are not allowed.

Eligible Applicant Types

00, 01, 02, 04, 05, 06, 07, 08, 11, 12, 13, 20, 22, 23, 25

Section III

Description

This Notice of Funding Opportunity (NOFO) encourages collaborations between the life and physical sciences that: 1) apply a multidisciplinary bioengineering approach to the solution of a biomedical problem; and 2) integrate, optimize, validate, translate or otherwise accelerate the adoption of promising tools, methods, and techniques for a specific research or clinical problem in basic, translational, or clinical science and practice. An application may propose design-directed, developmental, discovery-driven, or hypothesis-driven research and is appropriate for small teams applying an integrative approach to increase our understanding of and solve problems in biological, clinical, or translational science. This NOFO will support clinical trials that test functionality or validate performance in the chosen setting. This NOFO is not intended to support conventional clinical trials that lack translation as the primary motivation. Applications that propose phase III clinical trials in any area of research are not sought by and will not be supported through this NOFO. This NOFO does not support commercial production.

Section IV

Key Dates

Posted
May 4, 2026
Closes
Jul 5, 2029
Archive
Sep 5, 2029